Clovis Oncology Inc EBIT margin
Quel est le EBIT margin de Clovis Oncology Inc?
Le EBIT margin de Clovis Oncology Inc est -161.75%
Quelle est la définition de EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin des entreprises dans Health Care secteur sur NASDAQ par rapport à Clovis Oncology Inc
Entreprises avec ebit margin similaire à Clovis Oncology Inc
- W Resources Plc a EBIT margin de -164.36%
- Haydale Graphene Industries plc a EBIT margin de -163.70%
- Nektar Therapeutics a EBIT margin de -163.64%
- Nicholas a EBIT margin de -162.88%
- SenSen Networks a EBIT margin de -162.60%
- Kiadis Pharma N.V a EBIT margin de -161.82%
- Clovis Oncology Inc a EBIT margin de -161.75%
- co.don AG a EBIT margin de -161.62%
- Noida Toll Bridge a EBIT margin de -161.17%
- Xcel Brands Inc a EBIT margin de -160.69%
- Durect Corp a EBIT margin de -160.60%
- Petros Pharmaceuticals a EBIT margin de -159.30%
- Xelpmoc Design and Tech a EBIT margin de -159.13%